The high cost of cancer drugs and what we can do about it

Mayo Clin Proc. 2012 Oct;87(10):935-43. doi: 10.1016/j.mayocp.2012.07.007.
No abstract available

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use
  • Biomedical Technology / economics*
  • Biomedical Technology / statistics & numerical data
  • Drug Costs / statistics & numerical data*
  • Drug Costs / trends
  • Drug Utilization Review
  • Humans
  • Medical Oncology / economics
  • Neoplasms / economics*
  • Neoplasms / epidemiology
  • Neoplasms / therapy
  • Pharmacoepidemiology / economics*
  • Pharmacoepidemiology / statistics & numerical data
  • Pharmacovigilance
  • United States
  • United States Food and Drug Administration

Substances

  • Antineoplastic Agents